作为运动现象的G-四重复的多元多态性
Iztok Prislan1, Jurij Lah, Gorazd Vesnaver
1University of Ljubljana, Faculty of Chemistry and Chemical Technology, Askerceva 5, 1000 Ljubljana, Slovenia.
Journal of the American Chemical Society
|October 2, 2008
概括
一个新的运动模型准确地描述了G-四重复的折叠和展开,为所有步骤提供了积极的激活能量. 这有助于我们更好地理解G-quadruplex动态,这对细胞过程至关重要.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 结构生物学 结构生物学
背景情况:
- 在细胞过程中,G-四重复体至关重要,理解它们的结构转变是关键.
- 现有的G-四重复形成的动力模型产生不切实际的负激活能量.
- 分子间G-四重复体中的多态性表明动力控制的形成.
研究的目的:
- 开发一种新的动力模型,用于G-quadruplex折叠/展开过渡.
- 为了研究双分子G-四重复的多态行为.
- 为了确定G-四方体形成和解离的精确激活能量.
主要方法:
- 综合热力学和动力学研究.
- 频谱技术 (UV,CD) 用于监测过渡.
- 热量测量技术 (DSC) 用于研究热量行为.
- 分析由d(G4T4G4) 和d(G4T4G3) 与Na+离子组成的G四复合体.
主要成果:
- 一个新的动力模型成功地描述了实验监测的G-四方体折叠/展开.
- 该模型为所有基本步骤产生正的激活能量,包括链联结.
- G-quadruplex拓是灵活的,具有对温度变化速率敏感的形状形式.
结论:
- 拟议的运动模型准确地反映了G-四重复力学.
- 准确的动力参数对于理解G-四重复形状转换是必不可少的.
- G-四重复的灵活性和取决于温度的形状变化是显著的.
相关概念视频
Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Bacterial RNA Polymerase
Unlike eukaryotes, bacteria use a single RNA Polymerase (RNAP) to transcribe all genes. The different subunits of bacterial RNAPhave distinct functions. The multisubunit structure of the bacterial RNAP helps the enzyme to maintain catalytic function, facilitate assembly, interact with DNA and RNA, and self-regulate its activity.
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...
DNA Topoisomerases
Topoisomerases are enzymes that relax overwound DNA molecules during various cell processes, including DNA replication and transcription. These enzymes regulate positive and negative DNA supercoiling without changing the nucleotide sequence. DNA overwinding in a clockwise direction results in positively supercoiled DNA, whereas underwinding in a counterclockwise direction produces negatively supercoiled DNA.
Types and Mechanism of action
Topoisomerases are divided into two main types. Type I...
Types and Mechanism of action
Topoisomerases are divided into two main types. Type I...
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...


